secwatch.observer — SEC 8-K summary
======================================

Issuer:     GoodRx Holdings, Inc. (GDRX)
CIK:        0001809519
Form:       8-K
Filed at:   2023-06-06T23:59:59+00:00
Accession:  0000950170-23-026663
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

GoodRx board member Jacqueline Kosecoff resigns; triggers Nasdaq audit committee non-compliance
--------------------------------------------------------------------------------

- Jacqueline Kosecoff resigns from GoodRx Board, effective June 30, 2023, citing personal and professional commitments.
- Resignation creates vacancy on Audit Committee, causing non-compliance with Nasdaq Rule 5605(c)(2)(A).
- Company notified Nasdaq and will rely on cure period under Rule 5605(c)(4)(B) to regain compliance.
- Kosecoff to remain as advisor to GoodRx after resignation; no disagreement with management.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1809519/000095017023026663/0000950170-23-026663-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1809519/000095017023026663/gdrx-20230605.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-026663

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer